Covid Vaccination Argentina

[FrankPintor]

What do you consider to be useful? I believe it is about 50-60% after the first dose, and goes above 90% a couple of weeks after the second one.
For example, apparently people who wear eyeglasses (normal ones) have about 30% less probability to get infected. Is this useful?

Or it may be because Israel has twice more people fully vaccinated (percentage wise) than Chile.

These are the relevant quotes from the EMOL articles, they don't correspond with what you believe:

"los análisis de efectividad de Sinovac, según dosis aplicada, es la siguiente: - Para solo 1 dosis: 3% efectividad - Para 2 dosis, pero la segunda en menos de 14 días: 27,7% efectividad - Para 2 dosis y la segunda hace dos semanas o más: 56,5% efectividad"

Fuente: Emol.com - https://www.emol.com/noticias/Nacio...rimer-estudio-efectividad-sinovac-uchile.html

And also:

"El estudio, indica que existe una efectividad estimada de un 54% para la vacuna Sinovac en Chile, considerando a personas con segunda dosis completa (es decir, más de 14 días desde su inoculación)".

Fuente: Emol.com - https://www.emol.com/noticias/Nacio...desafios-primer-estudio-vacunacion-chile.html

Does any of that sound useful to you?

 

[lunar]

Does any of that sound useful to you?

EMA thinks it is useful. (I mean the level in general).

COVID-19 vaccines: studies for approval | European Medicines Agency (EMA)

The European Medicines Agency (EMA) needs many detailed studies to confirm that a vaccine is safe, provides adequate protection and is of suitable quality. As a public-health body safeguarding medicines in the European Union (EU), EMA only recommends approval of a vaccine for COVID-19 after a...

www.ema.europa.eu

...medicine developers should design studies to demonstrate a rate of efficacy of at least 50%.

 

[camberiu]

Pls refer to BMJ report posted earlier - both of the Chinese and Russian vaccines (e.g. those used here in Argentina) effectiveness against infection from variants including the Manaus are still classed as “unknown”.

CoronaVac first dose is effective against Manaus Covid-19 variant – preliminary study

Coronavac is the Brazilian made version of the Chinese vaccine.

 

[lunar]

CoronaVac first dose is effective against Manaus Covid-19 variant – preliminary study

Coronavac is the Brazilian made version of the Chinese vaccine.

This is not surprising. Inactivated vaccines should do better with new mutated strains.

 

[antipodean]

CoronaVac first dose is effective against Manaus Covid-19 variant – preliminary study

Coronavac is the Brazilian made version of the Chinese vaccine.

Meanwhile in Peru 7 doctors vaccinated with Sinopharm (the other commonly used vaccine in Argentina) have been infected with COVID, where the Manaus and UK strains are rampant. What’s worrying is that 3 of them who only received the first dose are now admitted to intensive care due to the severity of their condition.

Siete médicos de Perú vacunados contraen COVID-19 – DW – 04/04/2021

Tres de los galenos habían recibido solo la primera dosis de la vacuna y se encuentran en cuidados intensivos.

www.dw.com

 

[FrankPintor]

Meanwhile in Peru 7 doctors vaccinated with Sinopharm (the other commonly used vaccine in Argentina) have been infected with COVID, where the Manaus and UK strains are rampant. What’s worrying is that 3 of them who only received the first dose are now admitted to intensive care due to the severity of their condition.

Siete médicos de Perú vacunados contraen COVID-19 – DW – 04/04/2021

Tres de los galenos habían recibido solo la primera dosis de la vacuna y se encuentran en cuidados intensivos.

www.dw.com

That report is interesting. They don't say how soon after the first dose the 3 doctors ended up in intensive care, only this: "Es importante decir que estos (tres) médicos que están en la unidad de cuidados intensivos habían recibido (solamente) la primera dosis y luego se infectaron. No llegaron a completar la segunda dosis"

Update on my gf's kindergarden: the families of 2 kids in one bubble have COVID cases. It remains to be seen if the teacher will test positive (all teachers tested again today), and if the school will inform the families of the other kids in that bubble. Plus another teacher is showing symptoms (together with her husband). If your criterion for being worried is "dropping like flies", then we're not there yet, but IMHO the trend is not reassuring.

 

[antipodean]

China admitió que la eficacia de sus vacunas contra el COVID-19 no es alta

El director de los Centros de Control de Enfermedades, Gao Fu, reveló que las autoridades están considerando distintas opciones como modificar los intervalos de aplicación e incluso nuevas tecnologías para buscar elevar la inmunización

www.infobae.com

It appears even the Chinese government are now critical of Sinopharm and Sinovac.

Given the issues around keeping up with mutations etc, we may be lucky that new drugs for treatment of COVID are in phase 3 testing. Perhaps at the end of the day it won’t be vaccines alone that end the pandemic but tamiflu-style remedies to minimize deaths and serious cases?

 

[lunar]

It appears even the Chinese government are now critical of Sinopharm and Sinovac.

Apparently, he didn't criticize the vaccines, but just said that there is a place for improvement.

Exclusive: Chinese CDC director refutes interpretation of ‘low protection rate of Chinese vaccines,’ says it confuses scientific vision he proposes to improve efficacy - Global Times

www.globaltimes.cn

By the way, it looks like China only accepts people vaccinated by a Chinese vaccine.

Traveling to China during Covid-19: What you need to know before you go | CNN

If you're planning a trip to China, here's what you'll need to know and expect if you want to visit during the global coronavirus pandemic.

edition.cnn.com

For the newly qualified entrants, entry depends on having received two doses of Chinese-made Covid-19 vaccines at least 14 days prior to entry.

 

[FrankPintor]

Most of the criticism / wishes for improvement (with hard numbers from Chile, as I mentioned previously in this thread) seem to be focused on SinoVac, not so much on Sinopharm, which has reported 70-80% efficacy in trials. Given that the SinoVac data was available quite some time ago, the poor real-world performance looks like criminal irresponsibility on the part of the countries using it. Chile's daily cases are above 8000 again today, there has certainly been no let up there. Uruguay is also using SinoVac and it's doesn't look good there either. Brazil is producing SinoVac and has a genocidal nutcase president, it looks awful there.

Closer to here, I mentioned in a previous post what exponential COVID growth will do to ICU bed occupancy, that is, exhaust the capacity of the health system within a week. It didn't take long, really not much more than a week, and it looks like we're there already:

Fuerte advertencia del ministro de Salud bonaerense sobre la ocupación de camas por coronavirus: “El sistema puede colapsar pronto”

Daniel Gollán advirtió que el nivel de internados es “como el peor momento del año pasado”. Dijo que la propagación del virus va más rápido que la vacunación y, además, cuestionó que se permita comprar inoculantes a las provincias: “Va a aparecer un mercado negro”

www.infobae.com

Casi no quedan camas de terapia intensiva en hospitales y clínicas privadas de la Ciudad de Buenos Aires

Los principales sanatorios de CABA se encuentran ocupados entre el 95 y 100 por ciento según confirmaron a Infobae fuentes de la Unión Argentina de Salud. La titular del PAMI advirtió que no hay camas de terapia COVID para sus afiliados

www.infobae.com

There are times when I would prefer not to be right, and this is one of them.

My personal go-to indicator, the length of the queue to be tested outside CEMIC, was half a block today, down from one and a half blocks during the week, but maybe it's only because it's Sunday.

 

[camberiu]

China admitió que la eficacia de sus vacunas contra el COVID-19 no es alta

El director de los Centros de Control de Enfermedades, Gao Fu, reveló que las autoridades están considerando distintas opciones como modificar los intervalos de aplicación e incluso nuevas tecnologías para buscar elevar la inmunización

www.infobae.com

It appears even the Chinese government are now critical of Sinopharm and Sinovac.

When put into context, I don't think he is "admitting" Chinese vaccines' effectiveness is low; rather, he's "admitting" the mRNA approach (Pfizer, Moderna, J&J) can be much superior, so China should invest into the new technology instead of being complacent about the traditional vaccines it had developed.
The Chinese vaccine has a 50% effectiveness in preventing any kind of infection, but effectiveness in preventing serious cases resulting in hospitalization or death is close to 100%. The 50% of cases are mild symptoms. This vaccine shouldn’t be discouraged if no alternatives are available, since it will still save lives when administered.

Source: https://en.wikipedia.org/wiki/CoronaVac